🧹 Spring Clean Your Portfolio — code ANNUAL30 for 30% off your first yearEnds in --d --h --m --sSign up now →
2.81B6.1%
Total Revenue QoQ (NONE) - Q4 '25

Sign up to access historical data

Sign up

Income Statement (NONE)

Q4 '25 QoQ
Revenue 2.81B 6.1%
Operating expense 3.14B 0.8%
Net Income -353M 156.5%
EBITDA -346M 176.6%

Balance Sheet (NONE)

Q4 '25 QoQ
Total Assets 6.33B 10.1%
Total Liabilities 5.34B 13.3%
Total Equity 978M 4.5%
Shares Outstanding 283M 9.2%

Cash Flow (NONE)

Q4 '25 QoQ
Cash from operations 672M 169.7%
Cash from investing -49M 132.5%
Cash from financing 8.2M 97.8%

EPS

Only available for members.

Financial Highlights for Oscar Health in Q4 '25

Oscar Health reported a revenue of 2.81B, which is a -6.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. A decline in revenue can be concerning, as it might indicate reduced sales or challenges in the market. It's important to investigate further to understand the underlying causes.

Operating Expenses for this period were 3.14B, showing a 0.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.

Net Income for the quarter was -353M, showing a -156.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.

The company's EBITDA for the quarter was -346M, showing a -176.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.

Oscar Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.